Abstract:Precision medicine is becoming the goal of translational research on colorectal cancer. Accurate molecular subtyping contributes to better guidance of clinical practice. The current TNM staging system of colorectal cancer is inadequate in terms of guiding clinical practice, such as the underestimation of prognosis of with stage II( and III( colorectal cancer TNM staging, and identification of high-risk and low-risk patients with stage II( colorectal cancer. Researchers from Europe and US have proposed a number of molecular subtypings with clinicopathological phenotypes and molecular phenotypes, which has certain practical significance and is beneficial to the choice of treatment regimen and targeted drugs. But the current results of subtyping research require further validations by clinical large scale multi-center trials. Based on precision medicine, molecular subtyping gradually reveals its clinical significance and is optimized through combining genomics with various clinical phenotypes, indicating its guidance for clinical practice, which is the inevitable course of precision medicine accomplishment. In recent years, there have been many new advances in colorectal cancer liver metastasis treatment. The prognosis of colorectal cancer patients undergoing resection of liver metastasis lesion is similar to those with stage III(. Early recurrence within 6 months after translational treatment and resection occurred in about one third of the patients with initially unresectable liver metastasis, and the overall survival was poor. Thus, an evaluation system should be established in order to avoid the strong therapy and strive for better quality of life in some patients. Individualized treatment for colorectal cancer is emphasized increasingly. Body fluid (peripheral blood and urine) marker detection is a recent research hotspot, including serum protein(polypeptide), plasma miRNA, circulating tumor cells and circulating nucleic acid.

[How to carry out the translational medicine research effectively in gastrointestinal tumors].

Tumor Treatment Based on Translational Medicine

The practice and development of translational medicine in the diagnosis and treatment of gastrointestinal malignancy

Translational research on gastric cancer: Ruijin experience

[Research Progression of Translational Medicine in Gastric Cancer].

[Translational Medicine of Colorectal Cancer].

Translational Medicine:From Concept to Practice

Importance of translational medicine education in training graduate students of oncology

Translational Medicine: Advancing Medical Science by Stimulating Interdisciplinary Research

Hepatobiliary Surgery in the Era of Translational Medicine

Translational Research of the Relationship Between Rapamycin and Hepatocellular Carcinoma

Exploration and practice of translational medicine--discussion on the practice of the translational medicine in Shanghai East Hospital

Gastrointestinal stromal tumors and translational medicine

Research Progress of Translational Medicine Based on Tumor Molecular Biomarkers

Advances in translational medicine for individualized diagnosis of diseases

[New progression of translational research on colorectal cancer].

Translational Medicine in Primary Liver Cancer

Translational Gap in Glioma Research

Translational progress on tumor biomarkers.

The translational medicine study for acute graft-versus-host-disease after liver transplantation

Translational Medicine: from Basic Research to Clinical Application